Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in LGND — Ligand Pharmaceuticals Inc

CIK 72971 SAN FRANCISCO, CA
Back to LGND Full portfolio

Position in LGND

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$18,108,161
+$1,157,678 QoQ
Shares Held
57,288
-32.5% QoQ
Ownership
0.287%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#62
of 415 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LGND Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. LGND ranks #13 (1.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in LGND

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $18,108,161 57,288
2026-03-31 $16,950,483 84,901
2025-12-31 $25,077,486 132,636
2025-09-30 $20,402,451 115,177
2025-06-30 $1,505,235 13,241
2025-03-31 $1,346,317 12,805
2024-12-31 $1,202,222 11,220
2024-09-30 $865,778 8,650
2024-06-30 $742,414 8,811
2024-03-31 $500,733 6,850
2023-12-31 $405,664 5,680
2023-09-30 $270,297 4,511
2023-06-30 $566,920 7,863
2023-03-31 $304,683 4,142
2022-12-31 $133,732 2,002
2022-09-30 $229,481 2,665
2022-06-30 $258,825 2,901
2022-03-31 $2,441,594 21,705
2021-12-31 $5,741,275 37,170
2021-09-30 $6,133,140 44,022
2021-06-30 $4,754,586 36,242
2021-03-31 $6,324,077 41,483
2020-12-31 $3,503,520 35,229
2020-09-30 $5,189,885 54,447
2020-06-30 $8,343,893 74,599
2020-03-31 $6,819,092 93,772